Family Planning

ECHO Trial Results

Results from the ECHO trial have found no link between injectable contraceptives and risk of HIV infection, but the need for quality contraceptive care remains vital.

FIGO at RCOG World Congress

FIGO joins National Member Society, the Royal College of Obstetricians & Gynaecologists (RCOG) at their World Congress in 2019 to share global expertise in women's health...

What is quality family planning counselling?

FIGO joins the family planning community at the World Health Organization to address why there is still no consensus on how best to deliver and monitor quality contraceptive counselling.

Sharing the FP task in India

FIGO's postpartum IUD programme offers a roadmap for collaboration between doctors and nurses to scale up access to family planning in India...

Partnering with Midwives in Bangladesh

Increasing access to family planning is a critical strategy for reducing maternal mortality and morbidity - and an area where collaboration between women’s health professionals is key...

ICPD at 25: SRHR takes centre stage

FIGO welcomes the UNCPD declaration reaffirming support for the Programme of Action.

Evidence for Contraceptive options and HIV Outcomes

FIGO's Dr Anita Makins contributes to WHO Technical Consulation - Evidence for Contraceptive options and HIV Outcomes (ECHO) in Zambia...

Politics and Family Planning in Nepal

FIGO is proud to partner with the Nepal Society of Obstetricians and Gynaecologists (NESOG) in support of the Nepalese government’s pledge to extend family planning access in Nepal...

Think Equal: women's health, Nepal

Dr Kusum Thapa, NESOG President, explains why a gender-balanced world is our collective responsibility.

Think Equal: women's health, USA

Dr Jeanne Conry, FIGO President Elect, on why investing in women is an investment in this and future generations.